Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids

By Genç Mine   Castro Kreder Natasja   Barten-van Rijbroek Angelique   Stalpers Lukas   Haveman Jaap  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 45-51

Springer Publishing Company

Access to resources Recommend Favorite

Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype

By Hu Gang   Li Fu   Ouyang Kedong   Xie Fubo   Tang Xuzhen   Wang Ke   Han Sufang   Jiang Zhenzhou   Zhu Minghua   Wen Danyi   Qin Xiaoran   Zhang Luyong  

International Journal of Oncology, Vol. 40, Iss. 3, 2012-03 ,pp. : 798-806

Spandidos Publications

Access to resources Recommend Favorite

Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets

By                    

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1189-1196

Spandidos Publications

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs

By Bergman A.M.   Giaccone G.   van Moorsel C.J.A.   Mauritz R.   Noordhuis P.   Pinedo H.M.   Peters G.J.  

European Journal of Cancer, Vol. 36, Iss. 15, 2000-10 ,pp. : 1974-1983

Elsevier

Access to resources Recommend Favorite